Company: HCTI
Filing Date: 2025-04-22
Form Type: CORRESP
Source: 0001213900-25-034250
Chunk: 0

Company: Healthcare Triangle, Inc.
Filing Date: 2025-04-22
Form: CORRESP
Chunk 0
---
April 22, 2025

Via EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Technology

100 F. Street, NE

Washington, D.C. 20549

| Attention: | Aliya Ishmukhamedova / Matthew Crispino |

| Re: | Healthcare Triangle, Inc.                             
 Amendment No. 1 to Registration Statement on Form S-1 
 Submitted April 1, 2025                               
 File No. 333-286331                                   |

Ladies and Gentlemen:

On behalf of Healthcare Triangle, Inc. (the “Company”),
and pursuant to the applicable provisions of the Securities Act of 1933, as amended (the “Securities Act”), and the
rules and regulations promulgated thereunder, we are submitting with the Securities and Exchange Commission (the “Commission”),
via EDGAR, Amendment No. 1 to the Registration Statement on Form S-1 (the “Amended Registration Statement”), which
reflects revisions to the above-referenced Registration Statement submitted to the Commission on April 1, 2025 (and together with the
Amended Registration Statement, hereinafter referred to as the “Registration Statement”). The Registration Statement
has been revised in response to the comment letter addressed to the Company dated April 15, 2025, from the staff of the Commission (the
“Staff”), as well as certain other updated information.

Capitalized terms used
but not otherwise defined herein have the meanings set forth in the Amended Registration Statement.

For reference purposes, the comments contained in the Staff’s letter
dated April 15, 2025, are reproduced below in italics and the corresponding responses are shown below the comments. All references to
page numbers in the Company’s responses are to the page numbers in the Registration Statement.

| 1. | Staff Comment: We note your references in your prospectus to an "alternative                                                                  
 cashless exercise" of the Series B Warrants. The term "cashless exercise" is generally understood to allow a warrant holder                   
 to exercise a warrant without paying cash for the exercise price and reducing the number of shares receivable by the holder by an amount      
 equal in value to the aggregate exercise price the holder would otherwise pay to exercise the warrants. In cashless exercises, it is expected 
 that the warrant holder receives fewer shares than they would if they opted to pay the exercise price in cash. Please clarify your disclosure 
 throughout the prospectus